BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33071214)

  • 21. Phenotypic and cytogenetic analysis of atypical multidrug resistance in human leukaemic cells selected with methotrexate at high concentration.
    Kavallaris M; Haber M; Norris MD; Pittman SM; Reed C; Stewart BW
    Cancer Lett; 1990 Jun; 51(3):193-201. PubMed ID: 1972035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 may mediate the mdr-1 expression via the WT1 gene in human vincristine-resistant leukemia/lymphoma cell lines.
    Hirose M; Kuroda Y
    Cancer Lett; 1998 Jul; 129(2):165-71. PubMed ID: 9719458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein.
    Stam RW; van den Heuvel-Eibrink MM; den Boer ML; Ebus ME; Janka-Schaub GE; Allen JD; Pieters R
    Leukemia; 2004 Jan; 18(1):78-83. PubMed ID: 14574327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of multidrug resistant in cancer cells by EGCG, tannic acid and curcumin.
    Li H; Krstin S; Wink M
    Phytomedicine; 2018 Nov; 50():213-222. PubMed ID: 30466981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between decreased apoptosis and multidrug resistance (MDR) in murine leukemic T cell lines.
    Lopes EC; García MG; Vellón L; Alvarez E; Hajos SE
    Leuk Lymphoma; 2001 Aug; 42(4):775-87. PubMed ID: 11697508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of β-elemene on the kinetics of intracellular transport of d-luciferin potassium salt (ABC substrate) in doxorubicin-resistant breast cancer cells and the associated molecular mechanism.
    Tang CY; Zhu LX; Yu JD; Chen Z; Gu MC; Mu CF; Liu Q; Xiong Y
    Eur J Pharm Sci; 2018 Jul; 120():20-29. PubMed ID: 29704644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracellular pharmacodynamic studies of the synergistic combination of 6-mercaptopurine and cytosine arabinoside in human leukemia cell lines.
    Ramilo-Torno LV; Avramis VI
    Cancer Chemother Pharmacol; 1995; 35(3):191-9. PubMed ID: 7805176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of carrier-mediated transport of folates and antifolates in methotrexate-sensitive and-resistant leukemia cells.
    Jansen G; Mauritz RM; Assaraf YG; Sprecher H; Drori S; Kathmann I; Westerhof GR; Priest DG; Bunni M; Pinedo HM; Schornagel JH; Peters GJ
    Adv Enzyme Regul; 1997; 37():59-76. PubMed ID: 9381986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P-glycoprotein-mediated methotrexate resistance in CCRF-CEM sublines deficient in methotrexate accumulation due to a point mutation in the reduced folate carrier gene.
    Gifford AJ; Kavallaris M; Madafiglio J; Matherly LH; Stewart BW; Haber M; Norris MD
    Int J Cancer; 1998 Oct; 78(2):176-81. PubMed ID: 9754649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variegated clonality and rapid emergence of new molecular lesions in xenografts of acute lymphoblastic leukemia are associated with drug resistance.
    Nowak D; Liem NL; Mossner M; Klaumünzer M; Papa RA; Nowak V; Jann JC; Akagi T; Kawamata N; Okamoto R; Thoennissen NH; Kato M; Sanada M; Hofmann WK; Ogawa S; Marshall GM; Lock RB; Koeffler HP
    Exp Hematol; 2015 Jan; 43(1):32-43.e1-35. PubMed ID: 25450514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions between acute lymphoblastic leukemia and bone marrow stromal cells influence response to therapy.
    Tesfai Y; Ford J; Carter KW; Firth MJ; O'Leary RA; Gottardo NG; Cole C; Kees UR
    Leuk Res; 2012 Mar; 36(3):299-306. PubMed ID: 21889797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2.
    Dai CL; Liang YJ; Wang YS; Tiwari AK; Yan YY; Wang F; Chen ZS; Tong XZ; Fu LW
    Cancer Lett; 2009 Jun; 279(1):74-83. PubMed ID: 19232821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a membrane-associated folate-binding protein in human leukemic CCRF-CEM cells with transport-related methotrexate resistance.
    Jansen G; Westerhof GR; Kathmann I; Rademaker BC; Rijksen G; Schornagel JH
    Cancer Res; 1989 May; 49(9):2455-9. PubMed ID: 2706633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of methotrexate sensitivity in human leukemia cell lines by an adenosine triphosphate bioluminescence assay.
    Pinzani P; Carotti S; Gerli A; Pazzagli M; Mazzei T; Mini E
    Anticancer Drugs; 1997 Sep; 8(8):767-77. PubMed ID: 9396621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
    Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
    Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoxia influences stem cell-like properties in multidrug resistant K562 leukemic cells.
    Cui XY; Skretting G; Jing Y; Sun H; Sandset PM; Sun L
    Blood Cells Mol Dis; 2013 Oct; 51(3):177-84. PubMed ID: 23725749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance to drugs associated with the multidrug resistance phenotype following selection with high-concentration methotrexate.
    Haber M; Reed C; Kavallaris M; Norris MD; Stewart BW
    J Natl Cancer Inst; 1989 Aug; 81(16):1250-4. PubMed ID: 2754745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticancer drug-mediated induction of multidrug resistance-associated genes and protein kinase C isozymes in the T-lymphoblastoid cell line CCRF-CEM and in blasts from patients with acute lymphoblastic leukemias.
    Beck JF; Brügger D; Brischwein K; Liu C; Bader P; Niethammer D; Gekeler V
    Jpn J Cancer Res; 2001 Aug; 92(8):896-903. PubMed ID: 11509123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells.
    Svirnovski AI; Shman TV; Serhiyenka TF; Savitski VP; Smolnikova VV; Fedasenka UU
    Hematology; 2009 Aug; 14(4):204-12. PubMed ID: 19635183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased PKCα activity by Rack1 overexpression is responsible for chemotherapy resistance in T-cell acute lymphoblastic leukemia-derived cell line.
    Lei J; Li Q; Gao Y; Zhao L; Liu Y
    Sci Rep; 2016 Sep; 6():33717. PubMed ID: 27644318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.